Clinical Trials - Phase II
Filter News
Found 29,770 articles
-
Pfizer Inc. Oncology to Present New Clinical Data From Ten Molecules Across Multiple Tumor Types
5/20/2010
-
NewLink Genetics to Present Phase 2 Data on HyperAcute(R)-Pancreas Immunotherapy at the American Society of Clinical Oncology Annual Meeting
5/20/2010
-
Antigenics Inc. (Lexington, MA): Encouraging Data From University of California, San Francisco (UCSF) Phase I/II Study Presented on Oncophage(R) Vaccine at International Conference on Brain Tumor Research and Therapy
5/20/2010
-
NicOx SA Provides Strategic Update; Company Decides to Delay Initiation of Phase 2 Study of NCX 6560; Seeks Alternative Funding Options
5/19/2010
-
Actelion Ltd.'s REVEAL(R) Study May Advance Patient Care in Pulmonary Arterial Hypertension
5/19/2010
-
Vaxon Biotech SA Successfully Completes Its Phase I/II Trial Of Vx-001 Cancer Vaccine, Phase III Ready To Start In NSCLC
5/19/2010
-
Guardian Technologies International, Inc. to Begin Phase II Clinical Trials of Signature Mapping TBDx(TM) TB Diagnostics
5/19/2010
-
Targacept, Inc. Initiates Phase 2 Study of TC-5619 in Attention Deficit/Hyperactivity Disorder in Adults
5/19/2010
-
Stem Cell Therapeutics Announces the Date for the Release of Top-Line Results in the Modified REGENESIS Phase IIb Stroke Trial
5/19/2010
-
United States FDA Clears Mesoblast Limited Phase 2 Trial For Cervical Spinal Fusion
5/19/2010
-
OXiGENE Announces Clinical Data to be Presented at the 2010 Annual Meeting of the American Society of Clinical Oncology
5/19/2010
-
Allos Therapeutics, Inc.'s Pralatrexate Granted FDA Orphan Drug Designation for the Treatment of Bladder Cancer
5/18/2010
-
NexMed to Discuss P2/3 Protocol for NexACT(R)-Based Alprostadil Treatment for Raynaud's Syndrome with the FDA
5/18/2010
-
Pearl Therapeutics' Data for its Combination Bronchodilator Product, PT003, Support the Potential for Improvement in the Treatment of Patients with COPD
5/18/2010
-
Revotar Biopharmaceuticals Presents Positive Results In Phase IIa Ozone Study With Bimosiamose For COPD
5/18/2010
-
Cell Therapeutics, Inc.: Pixantrone Associated With Up to 4-Fold Reduction in Severe (Grade 3-4) Cardiac Toxicity When Compared to Doxorubicin in CHOP-R Regimen
5/18/2010
-
Immutep S.A. Announces Oral Presentation At American Society of Clinical Oncology Annual Meeting Of IMP321 Final Results In Phase I/II Chemoimmunotherapy Trial
5/18/2010
-
AEterna Zentaris Receives Positive Opinion for Orphan Medicinal Product Designation for AEZS-108 for the Treatment of Ovarian Cancer from the Committee for Orphan Medicinal Products of the European Medicines Agency
5/17/2010
-
Teva Pharmaceutical Industries Limited Says Lou Gehrig's Disease Drug Fails In Study
5/17/2010
-
Argos Therapeutics, Inc. Presents Phase 2a Data for Arcelis(TM) HIV Program Demonstrating Positive Impact on Viral Diversity and Viral Load
5/17/2010